368
Participants
Start Date
November 10, 2022
Primary Completion Date
July 14, 2026
Study Completion Date
March 23, 2027
Tezepelumab
Tezepelumab subcutaneous injection
Tezepelumab
Tezepelumab subcutaneous injection
Placebo
Placebo subcutaneous injection
Research Site, Vienna
Research Site, Lørenskog
Research Site, Otahuhu
Research Site, Kogarah
Research Site, Edegem
Research Site, Leuven
Research Site, Hamilton
Research Site, Woolloongabba
Research Site, Wels
Research Site, Køge
Research Site, Odense
Research Site, Elizabeth Vale
Research Site, Newtown
Research Site, Ålesund
Research Site, Christchurch
Research Site, Bruges
Research Site, Ghent
Research Site, Aalborg
Research Site, Brooklyn
Research Site, Athens
Research Site, Athens
Research Site, Athens
Research Site, Tomelloso
Research Site, Smithfield
Research Site, Philadelphia
Research Site, Rozzano
Research Site, Milan
Research Site, White Marsh
Research Site, Chapel Hill
Research Site, Madrid
Research Site, Madrid
Research Site, Madrid
Research Site, Pamplona
Research Site, Saint Augustine
Research Site, Jacksonville
Research Site, Inverness
Research Site, Padua
Research Site, Verona
Research Site, Nashville
Research Site, Bologna
Research Site, Seville
Research Site, Seville
Research Site, Cincinnati
Research Site, Chesterfield
Research Site, Iowa City
Research Site, Tel Litwinsky
Research Site, Pisa
Research Site, Thessaloniki
Research Site, Holon
Research Site, Normal
Research Site, Tel Aviv
Research Site, Topeka
Research Site, Lincoln
Research Site, Little Rock
Research Site, Houston
Research Site, Aurora
Research Site, Napoli
Research Site, München
Research Site, Salt Lake City
Research Site, Salt Lake City
Research Site, Phoenix
Research Site, Los Angeles
Research Site, Jerusalem
Research Site, Beijing
Research Site, Beijing
Research Site, Shenyang
Research Site, Shanghai
Research Site, Tianjin
Research Site, Hangzhou
Research Site, Wuhan
Research Site, Guangzhou
Research Site, Nanjing
Research Site, Petah Tikva
Research Site, Petah Tikva
Research Site, Tel Aviv
Research Site, Boston
Research Site, Ocean City
Research Site, South Brisbane
Research Site, Botucatu
Research Site, Brasília
Research Site, Caxias do Sul
Research Site, Curitiba
Research Site, Curitiba
Research Site, Porto Alegre
Research Site, São José do Rio Preto
Research Site, São Paulo
Research Site, Hamilton
Research Site, London
Research Site, Niagara Falls
Research Site, Ottawa
Research Site, Windsor
Research Site, Brno
Research Site, Hradec Králové
Research Site, Prague
Research Site, Helsinki
Research Site, Athens
Research Site, Roma
Research Site, Roma
Research Site, Akita
Research Site, Fukuoka
Research Site, Himeji
Research Site, Hiroshima
Research Site, Isehara-shi
Research Site, Kawasaki-shi
Research Site, Kitakyushu-shi
Research Site, Maebashi
Research Site, Minatoku
Research Site, Osaka
Research Site, Shinjuku-ku
Research Site, Shinjuku-ku
Research Site, Yamagata
Research Site, Amsterdam
Research Site, Nijmegen
Research Site, Rotterdam
Research Site, Lørenskog
Research Site, Oslo
Research Site, Tromsø
Research Site, Košice
Research Site, Barcelona
Research Site, Barcelona
Research Site, Stockholm
Research Site, Trollhättan
Research Site, Uppsala
Research Site, London
Research Site, London
Lead Sponsor
Collaborators (1)
Amgen
INDUSTRY
AstraZeneca
INDUSTRY